Mobile Cardiac Telemetry Patents: Who Leads, Where Filings Cooled 2026
Mobile cardiac telemetry patents: who holds the claim space and where it is still open
One assignee holds 29 of 96 records, and the top five combined account for 86.5% of all records in scope — a field concentrated at the very top. Filings climbed from 6 in 2017 to a peak of 19 in 2021, then fell to 5 by 2024 — a -74% decline over that three-year span. Because publication lags filing by roughly 18 months, 2025 and 2026 figures are still incomplete and should not yet be read as a continued slide.
- 1IRHYTHM TECHNOLOGIES INC29
- 2ZOLL MEDICAL CORPORATION28
- 3ACS DIAGNOSTICS INC12
- 4INFOBIONIC INC11
- 5PARALE GURUNATH PURUSHOTTAM3
See the full mobile cardiac telemetry services analysis in Eureka
- The complete ranking, not just the top five
- Every IPC branch with its share of the corpus
- The most-cited records, and where claim space is still thin
Common questions about mobile cardiac telemetry patents
Who holds the most patents in mobile cardiac telemetry?
One assignee leads the ranked list with 29 of the 96 records in scope, well ahead of the rest of the field. The top five assignees combined account for 86.5% of all records, and the top ten reach 97.9%, so the field is concentrated among a small number of established players rather than spread across many active filers. Anyone assessing freedom to operate should start with that leading portfolio before looking further down the ranking.
Is patent filing in mobile cardiac telemetry growing or slowing?
Filings rose through the late 2010s and peaked at 19 in 2021, then fell to 5 by 2024 — a -74% decline over that three-year span. That drop reflects genuine consolidation in complete-year data, but 2025 and 2026 figures are still incomplete because publication typically lags filing by about 18 months. The safest reading is that the initial claiming rush has passed, not that new filing has stopped entirely.
What technology areas do these patents cover?
Nearly all records, 94.8% of the 96 in scope, carry an A61B classification covering diagnosis and surgical monitoring equipment, which is the technical core of ambulatory ECG sensing. Secondary classes include G06F (digital data processing), A61N (electrotherapy) and G16H (healthcare informatics), each appearing on about a quarter of records, marking the software and workflow layers as the more actively contested secondary ground. Narrower classes like A61H, G09B, A24D and B65D appear on only a handful of records each.
Disclaimer. This analysis is based on Patsnap Eureka data drawn from a limited snapshot of global patent records and is provided for general information and reference only. Patent data carries inherent limitations — recent filings are under-counted because of publication lag, counts may be on a record or family basis, classification and applicant-name data may contain errors or duplicates, and the underlying search query defines the scope shown — so the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing here is an exhaustive prior-art, novelty, freedom-to-operate or validity search, nor does it constitute legal, financial or professional advice, and it should not be relied upon as such. Verify independently and review with qualified patent and legal professionals before acting on it.
Method: Filing trend and technology composition. Derived from a Patsnap search on Mobile Cardiac Telemetry Services covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish. Every share divides by all records in scope. Data: Patsnap Eureka. See the full landscape report.